9 May 2022Immunoprecise Antibodies (IPA.V) and Biostrand and the war on diseaseJoseph Morton IPA.V Immunoprecise Antibodies (IPA.V) subsidiary Biostrand and VLAIO—Flanders Innovation and Entrepreneurship—the research fund of the Flemish regional government in Belgium—have greed on a 460,000-euro round of grant financing. This award…